# Single Ascending Oral Doses of SY-009 in Healthy Subjects

> **NCT04119947** · PHASE1 · COMPLETED · sponsor: **Suzhou Yabao Pharmaceutical R&D Co., Ltd.** · enrollment: 24 (actual)

## Conditions studied

- Diabetes

## Interventions

- **DRUG:** SY-009

## Key facts

- **NCT ID:** NCT04119947
- **Lead sponsor:** Suzhou Yabao Pharmaceutical R&D Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-03-01
- **Primary completion:** 2019-05-30
- **Final completion:** 2019-05-30
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2019-10-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04119947

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04119947, "Single Ascending Oral Doses of SY-009 in Healthy Subjects". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT04119947. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*